[ad_1] Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings outcomes right this moment. Complete revenues inched up 1%…
Browsing: Squibb
[ad_1] Drew Angerer/Getty Photos Information Bristol-Myers Squibb (NYSE:BMY) agreed to buy Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. Bristol-Myers (BMY)…
[ad_1] hapabapa Previously I’ve revealed articles about pharmaceutical corporations regularly and one of many recurring themes in these articles was…